Opioids

The opioid crisis in the United States continues to worsen with thousands dying each month, and those numbers predicted to…

The Eliminating Kickbacks and Recovery Act of 2018 (EKRA) is part of a group of laws that was recently passed by the United States…

On October 11, 2018, Philadelphia Councilman Bill Greenlee introduced legislation to regulate how pharmaceutical representatives…

In a statement released on November 2, 2018, accompanying the approval of Dsuvia, a new opioid analgesic, United States Food and…

On October 24, 2018, the SUPPORT for Patients and Communities Act became law after passing both the House and the Senate with…

On September 21, 2018, the Centers for Disease Control (CDC) issued a publication, “Implementing the CDC Guidelines for…

Arena Pharmaceuticals has been focused recently on researching and developing a non-opiate for the treatment of gastrointestinal…

On Wednesday afternoon, October 3, 2018, the United States Senate accomplished a rare feat – passing a bipartisan bill with a vote…

Earlier this month, a newly formed healthcare alliance announced the Addiction Recovery Medical Home (ARMH) model, an Alternative…

On September 18, 2018, the United States Food and Drug Administration (FDA) approved the final Opioid Analgesic Risk Evaluation…